Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

NCT01326117 is registered in ClinicalTrials.gov with Mark Feinglos as lead sponsor.

NCT NCT01326117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01326117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
Lead sponsor
Mark Feinglos
Phase
Phase 4
Overall status
Withdrawn
Start date
April 30, 2011
Completion date
December 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic gastroparesis, gastroparesis, nausea, vomiting